Varicella zoster virus (VZV) vaccine
US11045540B2 · kind B2 · utility
52Cited by
35References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 15, 2018 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Mar 15, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16734
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aspects of the disclosure relate to nucleic acid vaccines. The vaccines include at least one RNA polynucleotides having an open reading frame encoding at least one varicella zoster virus (VZV) antigen. Methods for preparing and using such vaccines are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.